169 related articles for article (PubMed ID: 29052385)
1. [Research advances on baicalin and baicalein as potential therapeutic agents for fibrotic disease].
Zhu QJ
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(7):1271-1276. PubMed ID: 29052385
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy.
Xiang H; Lei H; Liu Z; Liu Y; Li Y; Qiu Y; Xu L
Toxicol Appl Pharmacol; 2021 Aug; 424():115594. PubMed ID: 34044073
[TBL] [Abstract][Full Text] [Related]
3. Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors.
Gong WY; Zhao ZX; Liu BJ; Lu LW; Dong JC
Eur J Med Chem; 2017 Jan; 126():844-852. PubMed ID: 27960146
[TBL] [Abstract][Full Text] [Related]
4. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
[TBL] [Abstract][Full Text] [Related]
5. Baicalin protects mice against Salmonella typhimurium infection via the modulation of both bacterial virulence and host response.
Wu SC; Chu XL; Su JQ; Cui ZQ; Zhang LY; Yu ZJ; Wu ZM; Cai ML; Li HX; Zhang ZJ
Phytomedicine; 2018 Sep; 48():21-31. PubMed ID: 30195877
[TBL] [Abstract][Full Text] [Related]
6. Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics.
Noh K; Kang Y; Nepal MR; Jeong KS; Oh DG; Kang MJ; Lee S; Kang W; Jeong HG; Jeong TC
Molecules; 2016 Mar; 21(3):337. PubMed ID: 26978333
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity.
Woo KJ; Lim JH; Suh SI; Kwon YK; Shin SW; Kim SC; Choi YH; Park JW; Kwon TK
Immunobiology; 2006; 211(5):359-68. PubMed ID: 16716805
[TBL] [Abstract][Full Text] [Related]
8. Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells.
Ke M; Zhang Z; Xu B; Zhao S; Ding Y; Wu X; Wu R; Lv Y; Dong J
Int Immunopharmacol; 2019 Oct; 75():105824. PubMed ID: 31437792
[TBL] [Abstract][Full Text] [Related]
9. Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.
Chen H; Gao Y; Wu J; Chen Y; Chen B; Hu J; Zhou J
Cancer Lett; 2014 Nov; 354(1):5-11. PubMed ID: 25128647
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review.
Cui L; Yuan T; Zeng Z; Liu D; Liu C; Guo J; Chen Y
Biomed Pharmacother; 2022 Jul; 151():113191. PubMed ID: 35643068
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes.
Shen YC; Chiou WF; Chou YC; Chen CF
Eur J Pharmacol; 2003 Mar; 465(1-2):171-81. PubMed ID: 12650847
[TBL] [Abstract][Full Text] [Related]
12. Dose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis.
Zhu D; Wang S; Lawless J; He J; Zheng Z
PLoS One; 2016; 11(11):e0167125. PubMed ID: 27902752
[TBL] [Abstract][Full Text] [Related]
13. Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives.
Wang R; Wang C; Lu L; Yuan F; He F
Pharmacol Res; 2024 Jan; 199():107032. PubMed ID: 38061594
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of the natural compounds baicalein and baicalin on autoimmune diseases.
Xu J; Liu J; Yue G; Sun M; Li J; Xiu X; Gao Z
Mol Med Rep; 2018 Jul; 18(1):1149-1154. PubMed ID: 29845272
[TBL] [Abstract][Full Text] [Related]
15. Baicalin and its aglycone: a novel approach for treatment of metabolic disorders.
Fang P; Yu M; Shi M; Bo P; Gu X; Zhang Z
Pharmacol Rep; 2020 Feb; 72(1):13-23. PubMed ID: 32016847
[TBL] [Abstract][Full Text] [Related]
16. Baicalin and baicalein attenuate renal fibrosis
Hu Q; Gao L; Peng B; Liu X
Exp Ther Med; 2017 Oct; 14(4):3074-3080. PubMed ID: 28928802
[TBL] [Abstract][Full Text] [Related]
17. Latest research progress on anticancer effect of baicalin and its aglycone baicalein.
Wang L; Feng T; Su Z; Pi C; Wei Y; Zhao L
Arch Pharm Res; 2022 Aug; 45(8):535-557. PubMed ID: 35908250
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders.
Dinda B; Dinda S; DasSharma S; Banik R; Chakraborty A; Dinda M
Eur J Med Chem; 2017 May; 131():68-80. PubMed ID: 28288320
[TBL] [Abstract][Full Text] [Related]
19. An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways.
Hu Z; Guan Y; Hu W; Xu Z; Ishfaq M
Iran J Basic Med Sci; 2022 Jan; 25(1):14-26. PubMed ID: 35656442
[TBL] [Abstract][Full Text] [Related]
20. Two-Armed Activation of Bone Mineral Deposition by the Flavones Baicalin and Baicalein, Encapsulated in Polyphosphate Microparticles.
Wang XH; Guo YW; Tolba E; Kokkinopoulou M; Wiens M; Schröder HC; Müller WEG
Am J Chin Med; 2017; 45(3):533-555. PubMed ID: 28367715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]